Jessica Tassan
Stock Analyst at Piper Sandler
(1.09)
# 3,891
Out of 5,113 analysts
81
Total ratings
30.88%
Success rate
-11.94%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jessica Tassan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HNGE Hinge Health | Maintains: Overweight | $71 → $60 | $37.65 | +59.36% | 3 | Jan 9, 2026 | |
| ALHC Alignment Healthcare | Maintains: Overweight | $20 → $30 | $22.08 | +35.87% | 6 | Jan 6, 2026 | |
| CVS CVS Health | Reiterates: Overweight | $99 → $101 | $74.03 | +36.43% | 6 | Dec 10, 2025 | |
| OSCR Oscar Health | Upgrades: Overweight | $13 → $25 | $14.87 | +68.12% | 7 | Nov 26, 2025 | |
| UNH UnitedHealth Group | Maintains: Overweight | $423 → $417 | $294.02 | +41.83% | 9 | Oct 29, 2025 | |
| PHR Phreesia | Maintains: Overweight | $33 → $34 | $14.66 | +131.92% | 6 | Sep 5, 2025 | |
| EVH Evolent Health | Maintains: Overweight | $16 → $18 | $3.23 | +457.28% | 4 | Aug 28, 2025 | |
| HCAT Health Catalyst | Downgrades: Neutral | $8 → $4 | $2.19 | +82.65% | 12 | Aug 27, 2025 | |
| CTEV Claritev | Maintains: Overweight | $44 → $86 | $26.98 | +218.75% | 3 | Aug 15, 2025 | |
| DOCS Doximity | Maintains: Overweight | $65 → $69 | $38.73 | +78.16% | 4 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $288 → $272 | $194.01 | +40.20% | 4 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $10 → $8 | $4.78 | +67.36% | 3 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $348 → $374 | $272.38 | +37.31% | 4 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $12 | $5.74 | +109.06% | 6 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $66 → $70 | $49.04 | +42.74% | 4 | Aug 2, 2023 |
Hinge Health
Jan 9, 2026
Maintains: Overweight
Price Target: $71 → $60
Current: $37.65
Upside: +59.36%
Alignment Healthcare
Jan 6, 2026
Maintains: Overweight
Price Target: $20 → $30
Current: $22.08
Upside: +35.87%
CVS Health
Dec 10, 2025
Reiterates: Overweight
Price Target: $99 → $101
Current: $74.03
Upside: +36.43%
Oscar Health
Nov 26, 2025
Upgrades: Overweight
Price Target: $13 → $25
Current: $14.87
Upside: +68.12%
UnitedHealth Group
Oct 29, 2025
Maintains: Overweight
Price Target: $423 → $417
Current: $294.02
Upside: +41.83%
Phreesia
Sep 5, 2025
Maintains: Overweight
Price Target: $33 → $34
Current: $14.66
Upside: +131.92%
Evolent Health
Aug 28, 2025
Maintains: Overweight
Price Target: $16 → $18
Current: $3.23
Upside: +457.28%
Health Catalyst
Aug 27, 2025
Downgrades: Neutral
Price Target: $8 → $4
Current: $2.19
Upside: +82.65%
Claritev
Aug 15, 2025
Maintains: Overweight
Price Target: $44 → $86
Current: $26.98
Upside: +218.75%
Doximity
Aug 11, 2025
Maintains: Overweight
Price Target: $65 → $69
Current: $38.73
Upside: +78.16%
Jul 31, 2025
Maintains: Neutral
Price Target: $288 → $272
Current: $194.01
Upside: +40.20%
May 23, 2025
Reiterates: Neutral
Price Target: $10 → $8
Current: $4.78
Upside: +67.36%
May 5, 2025
Maintains: Overweight
Price Target: $348 → $374
Current: $272.38
Upside: +37.31%
Feb 27, 2025
Maintains: Overweight
Price Target: $13 → $12
Current: $5.74
Upside: +109.06%
Aug 2, 2023
Downgrades: Neutral
Price Target: $66 → $70
Current: $49.04
Upside: +42.74%